Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical EOPt18 028 018 2-d11 100UG
SDP

Supplier:  Cayman Chemical 9004339100 UG

Encompass_Preferred

A TNNI3K inhibitor and sorafenib derivative (IC50 10 nM) selective for TNNI3K over VEGFR2 p38a and B-RAF (IC50s 400 800 and >2000 nM respectively) reduces superoxide levels in isolated left ventricular tissues and infarct size in a mouse model of myocardial ischemia-reperfusion injury induced by LAD coronary artery occlusion at 2.75 mg/kg

Catalog No. 50-289-5804


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.